418 related articles for article (PubMed ID: 19070657)
21. Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
Gupta A; Unadkat JD; Mao Q
J Pharm Sci; 2007 Dec; 96(12):3226-35. PubMed ID: 17518356
[TBL] [Abstract][Full Text] [Related]
22. Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells.
Hou XL; Takahashi K; Kinoshita N; Qiu F; Tanaka K; Komatsu K; Takahashi K; Azuma J
Int J Pharm; 2007 Jun; 337(1-2):169-77. PubMed ID: 17270371
[TBL] [Abstract][Full Text] [Related]
23. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P-Glycoprotein Inhibitor (Itraconazole).
Kobayashi K; Abe Y; Kawai A; Furihata T; Endo T; Takeda H
J Clin Pharmacol; 2020 Oct; 60(10):1314-1323. PubMed ID: 32459872
[TBL] [Abstract][Full Text] [Related]
25. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
26. [The drug-drug interaction mediated by efflux transporters and CYP450 enzymes].
Wang C; Liu KX
Yao Xue Xue Bao; 2014 May; 49(5):590-5. PubMed ID: 25151726
[TBL] [Abstract][Full Text] [Related]
27. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.
Hellum BH; Nilsen OG
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):466-75. PubMed ID: 18331390
[TBL] [Abstract][Full Text] [Related]
28. Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate.
Ebert B; Seidel A; Lampen A
Toxicol Sci; 2007 Apr; 96(2):227-36. PubMed ID: 17077187
[TBL] [Abstract][Full Text] [Related]
29. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole.
Paine MF; Schmiedlin-Ren P; Watkins PB
Drug Metab Dispos; 1999 Mar; 27(3):360-4. PubMed ID: 10064566
[TBL] [Abstract][Full Text] [Related]
31. Cyprodinil as an activator of aryl hydrocarbon receptor.
Fang CC; Chen FY; Chen CR; Liu CC; Wong LC; Liu YW; Su JG
Toxicology; 2013 Feb; 304():32-40. PubMed ID: 23228475
[TBL] [Abstract][Full Text] [Related]
32. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
[TBL] [Abstract][Full Text] [Related]
33. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
[TBL] [Abstract][Full Text] [Related]
34. Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation.
Maayah ZH; El Gendy MA; El-Kadi AO; Korashy HM
Arch Toxicol; 2013 May; 87(5):847-56. PubMed ID: 23288144
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cells.
Chae YJ; Cho KH; Yoon IS; Noh CK; Lee HJ; Park Y; Ji E; Seo MD; Maeng HJ
Planta Med; 2016 Jan; 82(1-2):121-30. PubMed ID: 26366751
[TBL] [Abstract][Full Text] [Related]
36. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
37. TCDD-induced CYP1A1 expression, an index of dioxin toxicity, is suppressed by flavonoids permeating the human intestinal Caco-2 cell monolayers.
Hamada M; Satsu H; Natsume Y; Nishiumi S; Fukuda I; Ashida H; Shimizu M
J Agric Food Chem; 2006 Nov; 54(23):8891-8. PubMed ID: 17090139
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Lempers VJ; van den Heuvel JJ; Russel FG; Aarnoutse RE; Burger DM; Brüggemann RJ; Koenderink JB
Antimicrob Agents Chemother; 2016 Jun; 60(6):3372-9. PubMed ID: 27001813
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of the carcinogen-metabolizing enzyme cytochrome P450 1a1 by vanadium.
Anwar-Mohamed A; El-Kadi AO
Drug Metab Dispos; 2008 Sep; 36(9):1819-27. PubMed ID: 18541696
[TBL] [Abstract][Full Text] [Related]
40. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.
Fretland AJ; Safe S; Hankinson O
Chem Biol Interact; 2004 Nov; 150(2):161-70. PubMed ID: 15535986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]